East African Pharmaceutical Market, Forecast to 2021

East African Pharmaceutical Market, Forecast to 2021

Generic Pharmaceutical Products Continue to Dominate with Increased Foreign Direct Investment by Asian Manufacturers

RELEASE DATE
27-Sep-2017
REGION
Africa
Research Code: MCFC-01-00-00-00
SKU: HC02898-AF-MR_20867
AvailableYesPDF Download

$4,950.00

Special Price $3,712.50 save 25 %

In stock
SKU
HC02898-AF-MR_20867

$4,950.00

$3,712.50save 25 %

DownloadLink
ENQUIRE NOW

Description

Pharmaceutical markets in Sub-Saharan Africa are experiencing rapid growth as governments and healthcare providers battle with their respective burdens of disease. The continent has one of the highest burdens of disease, such as HIV, malaria, and tuberculosis, yet has limited healthcare resources and spending. As such there are great opportunities for growth in the pharmaceutical sector. While control and eradication of communicable diseases has been an ongoing priority area for governments, non-communicable diseases have now become an area of concern for the continent. This is driven by various factors that are mentioned in this study. In East Africa, the outlook of the healthcare environment is similar to that of the rest of Africa. The countries generally share similar climate conditions, language, and disease prevalence. While significant strides have been made in healthcare provision, funding, infrastructure development and technology, the pharmaceutical sector in the region as a whole in East Africa is still much smaller than that of other regions in Africa, even though it has a higher population. Significant investments by multinational companies are driving growth using different proven business models. The focus on universal healthcare, providing coverage for each citizen, particularly the poor and vulnerable, is a focal point for governments. With multiple participants in the region, including emerging leaders with high growth rates in the continent, pharmaceuticals in the region will now become more important than ever in the drive for better healthcare and the effort to meet millennium development goals. Some therapeutic areas in the countries under this study are now growing, giving an indication of future pharmaceutical opportunities.

The study covers the following pharmaceutical segments: cardiovascular, oncology, respiratory, anti-infective, and central nervous system.

Highlights of the report include:
• Market overview and projections for the pharmaceutical market (2016–2021)
• Revenue forecast and breakdown by therapeutic area
• Revenue forecast by country and therapeutic segment analysis
• Key trends, key participants, participant strategies, competitive environment analysis, and growth opportunities
• Strategic recommendations and future outlook of pharmaceutical market

Key questions this study will answer include:
• Is the East African pharmaceutical market growing? How long will it continue to grow and at what rate?
• How is the East African pharmaceutical market structured and who are the key competitors in the market?
• What are the drivers, restraints, and challenges of the East African pharmaceutical market?
• How is the regulatory environment in the East African pharmaceutical market, and what is its future impact?
• Who are the main stakeholders in the East African pharmaceutical market?
• What are the growth opportunities in the East African pharmaceutical market?

RESEARCH: INFOGRAPHIC

This infographic presents a brief overview of the research, and highlights the key topics discussed in it.
Click image to view it in full size

Table of Contents

Key Findings

Scope and Segmentation

Market Engineering Measurements

The Last Word—3 Big Predictions

Market Overview—Segmentation

Market Overview—Global Market Perspective

Market Overview—Defining Healthcare Trends in the Future

Market Overview—New Market Opportunities

Market Engineering Measurements

Revenue Forecast

Percent Revenue Forecast by Country

Revenue Forecast by Country

Revenue Forecast by Therapeutic Segment

Growth Opportunity 1—Public-Private Partnerships

Growth Opportunity 2—Regulatory Reform

Growth Opportunity 3—API Manufacturing

Growth Opportunity 4—Vaccines Manufacturing

Strategic Imperatives for Pharmaceutical Companies

Kenya Overview

Kenya Healthcare Overview

Kenya Pharmaceutical Market Overview

Kenya Market Engineering Measurements

Kenya Revenue Forecast

Kenya Revenue Forecast by Therapeutic Segment

Kenya Market Share Analysis

Kenya Competitive Environment

Kenya Competitive Environment Assessment

Tanzania Overview

Tanzania Healthcare Overview

Tanzania Pharmaceutical Market Overview

Tanzania Market Engineering Measurements

Tanzania Revenue Forecast

Tanzania Revenue Forecast by Therapeutic Segment

Tanzania Market Share Analysis

Tanzania Competitive Environment

Tanzania Competitive Environment Assessment

Ethiopia Overview

Ethiopia Healthcare Overview

Ethiopia Pharmaceutical Market Overview

Ethiopia Market Engineering Measurements

Ethiopia Revenue Forecast

Ethiopia Revenue Forecast by Therapeutic Segment

Ethiopia Market Share Analysis

Ethiopia Competitive Environment

Ethiopia Competitive Environment Assessment

Uganda Overview

Uganda Healthcare Overview

Uganda Pharmaceutical Market Overview

Uganda Market Engineering Measurements

Uganda Revenue Forecast

Uganda Revenue Forecast by Therapeutic Segment

Uganda Market Share Analysis

Uganda Competitive Environment

Uganda Competitive Environment Assessment

Rwanda Overview

Rwanda Healthcare Overview

Rwanda Pharmaceutical Market Overview

Rwanda Market Engineering Measurements

Rwanda Revenue Forecast

Rwanda Revenue Forecast by Therapeutic Segment

Rwanda Market Share Analysis

Rwanda Competitive Environment

Rwanda Competitive Environment Assessment

The Last Word—3 Big Predictions

The Last Word—Discussion

Legal Disclaimer

Market Engineering Methodology

List of Figures
  • 1. Total Pharmaceutical Market: Defining Healthcare Trends in the Future, East Africa, 2016 and 2026
  • 2. Total Pharmaceutical Market: Key Market Drivers, East Africa, 2017–2021
  • 3. Total Pharmaceutical Market: Key Market Restraints, East Africa, 2017–2021
  • 4. Total Pharmaceutical Market: Market Engineering Measurements, East Africa, 2016
  • 5. Total Pharmaceutical Market: Revenue Forecast by Country, East Africa, 2013–2021
  • 6. Healthcare Indicators, Kenya, 2016
  • 7. Pharmaceutical Market: Market Engineering Measurements, Kenya, 2016
  • 8. Pharmaceutical Market: Top 5 Generic Participants’ Ranking, Kenya, 2016
  • 9. Pharmaceutical Market: Top 5 Branded Participants’ Ranking, Kenya, 2016
  • 10. Pharmaceutical Market: Competitive Structure, Kenya, 2016
  • 11. Healthcare Indicators, Tanzania, 2016
  • 12. Pharmaceutical Market: Market Engineering Measurements, Tanzania, 2016
  • 13. Pharmaceutical Market: Top 5 Generic Participants Ranking, Tanzania, 2016
  • 14. Pharmaceutical Market: Top 5 Branded Participants’ Ranking, Tanzania, 2016
  • 15. Pharmaceutical Market: Competitive Structure, Tanzania, 2016
  • 16. Healthcare Indicators, Ethiopia, 2016
  • 17. Pharmaceutical Market: Market Engineering Measurements, Ethiopia, 2016
  • 18. Pharmaceutical Market: Top 5 Generic Participants’ Ranking, Ethiopia, 2016
  • 19. Pharmaceutical Market: Top 5 Branded Participants’ Ranking, Ethiopia, 2016
  • 20. Pharmaceutical Market: Competitive Structure, Ethiopia, 2016
  • 21. Healthcare Indicators, Uganda, 2016
  • 22. Pharmaceutical Market: Market Engineering Measurements, Uganda, 2016
  • 23. Pharmaceutical Market: Top 5 Generic Participants’ Ranking, Uganda, 2016
  • 24. Pharmaceutical Market: Top 5 Branded Participants’ Ranking, Uganda, 2016
  • 25. Pharmaceutical Market: Competitive Structure, Uganda, 2016
  • 26. Healthcare Indicators, Rwanda, 2016
  • 27. Pharmaceutical Market: Market Engineering Measurements, Rwanda, 2016
  • 28. Pharmaceutical Market: Top 5 Generic Participants, Rwanda, 2016
  • 29. Pharmaceutical Market: Top 5 Branded Participants, Rwanda, 2016
  • 30. Pharmaceutical Market: Competitive Structure, Rwanda, 2016
List of Charts
  • 1. Total Pharmaceutical Market: Market Engineering Measurements, East Africa, 2016
  • 2. Total Pharmaceutical Market: Market Segmentation, East Africa, 2016
  • 3. Total Pharmaceutical Market: Percent Sales Breakdown, East Africa, 2016
  • 4. Total Pharmaceutical Market: Revenue Breakdown by Geographic Region, Global, 2016
  • 5. Total Pharmaceutical Market: Revenue Forecast, East Africa, 2013–2021
  • 6. Total Pharmaceutical Market: Percent Revenue Forecast by Country, East Africa, 2013–2021
  • 7. Total Pharmaceutical Market: Revenue Forecast by Therapeutic Segment, East Africa, 2013–2021
  • 8. Pharmaceutical Market: Revenue Forecast, Kenya, 2013–2021
  • 9. Pharmaceutical Market: Revenue Forecast by Therapeutic Segment, Kenya, 2013–2021
  • 10. Pharmaceutical Market: Revenue Forecast, Tanzania, 2013–2021
  • 11. Pharmaceutical Market: Revenue Forecast by Therapeutic Segment, Tanzania, 2013–2021
  • 12. Pharmaceutical Market: Revenue Forecast, Ethiopia, 2013–2021
  • 13. Pharmaceutical Market: Revenue Forecast by Therapeutic Segment, Ethiopia, 2013–2021
  • 14. Pharmaceutical Market: Revenue Forecast, Uganda, 2013–2021
  • 15. Pharmaceutical Market: Revenue Forecast by Therapeutic Segment, Uganda, 2013–2021
  • 16. Pharmaceutical Market: Revenue Forecast, Rwanda, 2013–2021
  • 17. Pharmaceutical Market: Revenue Forecast by Therapeutic Segment, Rwanda, 2013–2021
Related Research
Pharmaceutical markets in Sub-Saharan Africa are experiencing rapid growth as governments and healthcare providers battle with their respective burdens of disease. The continent has one of the highest burdens of disease, such as HIV, malaria, and tuberculosis, yet has limited healthcare resources and spending. As such there are great opportunities for growth in the pharmaceutical sector. While control and eradication of communicable diseases has been an ongoing priority area for governments, non-communicable diseases have now become an area of concern for the continent. This is driven by various factors that are mentioned in this study. In East Africa, the outlook of the healthcare environment is similar to that of the rest of Africa. The countries generally share similar climate conditions, language, and disease prevalence. While significant strides have been made in healthcare provision, funding, infrastructure development and technology, the pharmaceutical sector in the region as a whole in East Africa is still much smaller than that of other regions in Africa, even though it has a higher population. Significant investments by multinational companies are driving growth using different proven business models. The focus on universal healthcare, providing coverage for each citizen, particularly the poor and vulnerable, is a focal point for governments. With multiple participants in the region, including emerging leaders with high growth rates in the continent, pharmaceuticals in the region will now become more important than ever in the drive for better healthcare and the effort to meet millennium development goals. Some therapeutic areas in the countries under this study are now growing, giving an indication of future pharmaceutical opportunities. The study covers the following pharmaceutical segments: cardiovascular, oncology, respiratory, anti-infective, and central nervous system. Highlights of the report include: • Market overview and projections for the
More Information
No Index No
Podcast No
Table of Contents | Executive Summary~ || Key Findings~ || Scope and Segmentation~ || Market Engineering Measurements~ || The Last Word—3 Big Predictions~ | Market Overview~ || Market Overview—Segmentation~ || Market Overview—Global Market Perspective~ || Market Overview—Defining Healthcare Trends in the Future~ || Market Overview—New Market Opportunities~ | Drivers and Restraints—Total Pharmaceutical Market~ || Market Drivers~ || Market Restraints~ | Forecasts and Trends—Total Pharmaceutical Market~ || Market Engineering Measurements~ || Revenue Forecast~ || Percent Revenue Forecast by Country~ || Revenue Forecast by Country~ || Revenue Forecast by Therapeutic Segment~ | Growth Opportunities and Companies to Action~ || Growth Opportunity 1—Public-Private Partnerships~ || Growth Opportunity 2—Regulatory Reform~ || Growth Opportunity 3—API Manufacturing~ || Growth Opportunity 4—Vaccines Manufacturing~ || Strategic Imperatives for Pharmaceutical Companies~ | Kenya Analysis~ || Kenya Overview~ || Kenya Healthcare Overview~ || Kenya Pharmaceutical Market Overview~ || Kenya Market Engineering Measurements~ || Kenya Revenue Forecast~ || Kenya Revenue Forecast by Therapeutic Segment~ || Kenya Market Share Analysis~ || Kenya Competitive Environment~ || Kenya Competitive Environment Assessment~ | Tanzania Analysis~ || Tanzania Overview~ || Tanzania Healthcare Overview~ || Tanzania Pharmaceutical Market Overview~ || Tanzania Market Engineering Measurements~ || Tanzania Revenue Forecast~ || Tanzania Revenue Forecast by Therapeutic Segment~ || Tanzania Market Share Analysis~ || Tanzania Competitive Environment~ || Tanzania Competitive Environment Assessment~ | Ethiopia Analysis~ || Ethiopia Overview~ || Ethiopia Healthcare Overview~ || Ethiopia Pharmaceutical Market Overview~ || Ethiopia Market Engineering Measurements~ || Ethiopia Revenue Forecast~ || Ethiopia Revenue Forecast by Therapeutic Segment~ || Ethiopia Market Share Analysis~ || Ethiopia Competitive Environment~ || Ethiopia Competitive Environment Assessment~ | Uganda Analysis~ || Uganda Overview~ || Uganda Healthcare Overview~ || Uganda Pharmaceutical Market Overview~ || Uganda Market Engineering Measurements~ || Uganda Revenue Forecast~ || Uganda Revenue Forecast by Therapeutic Segment~ || Uganda Market Share Analysis~ || Uganda Competitive Environment~ || Uganda Competitive Environment Assessment~ | Rwanda Analysis~ || Rwanda Overview~ || Rwanda Healthcare Overview~ || Rwanda Pharmaceutical Market Overview~ || Rwanda Market Engineering Measurements~ || Rwanda Revenue Forecast~ || Rwanda Revenue Forecast by Therapeutic Segment~ || Rwanda Market Share Analysis~ || Rwanda Competitive Environment~ || Rwanda Competitive Environment Assessment~ | The Last Word~ || The Last Word—3 Big Predictions~ || The Last Word—Discussion~ || Legal Disclaimer~ | Appendix~ || Market Engineering Methodology~
List of Charts and Figures 1. Total Pharmaceutical Market: Defining Healthcare Trends in the Future, East Africa, 2016 and 2026~ 2. Total Pharmaceutical Market: Key Market Drivers, East Africa, 2017–2021~ 3. Total Pharmaceutical Market: Key Market Restraints, East Africa, 2017–2021~ 4. Total Pharmaceutical Market: Market Engineering Measurements, East Africa, 2016~ 5. Total Pharmaceutical Market: Revenue Forecast by Country, East Africa, 2013–2021~ 6. Healthcare Indicators, Kenya, 2016~ 7. Pharmaceutical Market: Market Engineering Measurements, Kenya, 2016~ 8. Pharmaceutical Market: Top 5 Generic Participants’ Ranking, Kenya, 2016~ 9. Pharmaceutical Market: Top 5 Branded Participants’ Ranking, Kenya, 2016~ 10. Pharmaceutical Market: Competitive Structure, Kenya, 2016~ 11. Healthcare Indicators, Tanzania, 2016~ 12. Pharmaceutical Market: Market Engineering Measurements, Tanzania, 2016~ 13. Pharmaceutical Market: Top 5 Generic Participants Ranking, Tanzania, 2016~ 14. Pharmaceutical Market: Top 5 Branded Participants’ Ranking, Tanzania, 2016~ 15. Pharmaceutical Market: Competitive Structure, Tanzania, 2016~ 16. Healthcare Indicators, Ethiopia, 2016~ 17. Pharmaceutical Market: Market Engineering Measurements, Ethiopia, 2016~ 18. Pharmaceutical Market: Top 5 Generic Participants’ Ranking, Ethiopia, 2016~ 19. Pharmaceutical Market: Top 5 Branded Participants’ Ranking, Ethiopia, 2016~ 20. Pharmaceutical Market: Competitive Structure, Ethiopia, 2016~ 21. Healthcare Indicators, Uganda, 2016~ 22. Pharmaceutical Market: Market Engineering Measurements, Uganda, 2016~ 23. Pharmaceutical Market: Top 5 Generic Participants’ Ranking, Uganda, 2016~ 24. Pharmaceutical Market: Top 5 Branded Participants’ Ranking, Uganda, 2016~ 25. Pharmaceutical Market: Competitive Structure, Uganda, 2016~ 26. Healthcare Indicators, Rwanda, 2016~ 27. Pharmaceutical Market: Market Engineering Measurements, Rwanda, 2016~ 28. Pharmaceutical Market: Top 5 Generic Participants, Rwanda, 2016~ 29. Pharmaceutical Market: Top 5 Branded Participants, Rwanda, 2016~ 30. Pharmaceutical Market: Competitive Structure, Rwanda, 2016~| 1. Total Pharmaceutical Market: Market Engineering Measurements, East Africa, 2016~ 2. Total Pharmaceutical Market: Market Segmentation, East Africa, 2016~ 3. Total Pharmaceutical Market: Percent Sales Breakdown, East Africa, 2016~ 4. Total Pharmaceutical Market: Revenue Breakdown by Geographic Region, Global, 2016~ 5. Total Pharmaceutical Market: Revenue Forecast, East Africa, 2013–2021~ 6. Total Pharmaceutical Market: Percent Revenue Forecast by Country, East Africa, 2013–2021~ 7. Total Pharmaceutical Market: Revenue Forecast by Therapeutic Segment, East Africa, 2013–2021~ 8. Pharmaceutical Market: Revenue Forecast, Kenya, 2013–2021~ 9. Pharmaceutical Market: Revenue Forecast by Therapeutic Segment, Kenya, 2013–2021~ 10. Pharmaceutical Market: Revenue Forecast, Tanzania, 2013–2021~ 11. Pharmaceutical Market: Revenue Forecast by Therapeutic Segment, Tanzania, 2013–2021~ 12. Pharmaceutical Market: Revenue Forecast, Ethiopia, 2013–2021~ 13. Pharmaceutical Market: Revenue Forecast by Therapeutic Segment, Ethiopia, 2013–2021~ 14. Pharmaceutical Market: Revenue Forecast, Uganda, 2013–2021~ 15. Pharmaceutical Market: Revenue Forecast by Therapeutic Segment, Uganda, 2013–2021~ 16. Pharmaceutical Market: Revenue Forecast, Rwanda, 2013–2021~ 17. Pharmaceutical Market: Revenue Forecast by Therapeutic Segment, Rwanda, 2013–2021~
Lightbox Content World Cancer Day 2019|Get 15% discount for all Healthcare studies |https://store.frost.com/contacts/?utm_source=PD&utm_medium=lightbox&utm_campaign=HEALTHCARE_CANCER2019
Author Takudzwa Musiyarira
Industries Healthcare
WIP Number MCFC-01-00-00-00
Is Prebook No
GPS Codes 9600-B1,9611-B1,9825-B1,99CB-B1,9A40-B1,9A43-B1